Diana Bolotin to Aged
This is a "connection" page, showing publications Diana Bolotin has written about Aged.
Connection Strength
0.144
-
Histologic Status of Squamous Cell Carcinoma In Situ After Diagnostic Biopsy in Immunocompetent and Immunosuppressed Patients. Dermatol Surg. 2018 Mar; 44(3):341-349.
Score: 0.045
-
Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study. J Am Acad Dermatol. 2024 Jun; 90(6):1243-1245.
Score: 0.017
-
Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery: A Prospective, Multicenter Cohort Study. JAMA Dermatol. 2022 07 01; 158(7):770-778.
Score: 0.015
-
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease. JAMA Oncol. 2022 04 01; 8(4):618-628.
Score: 0.015
-
Perineural spread of cutaneous squamous cell carcinoma along the great auricular nerve [corrected]. Ear Nose Throat J. 2015 Apr-May; 94(4-5):150-2.
Score: 0.009
-
Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures: lasers, energy devices, and injectable neurotoxins and fillers. JAMA Dermatol. 2015 Mar; 151(3):271-7.
Score: 0.009
-
Treatment of keratosis pilaris with 810-nm diode laser: a randomized clinical trial. JAMA Dermatol. 2015 Feb; 151(2):187-91.
Score: 0.009
-
Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers. JAMA Dermatol. 2013 Dec; 149(12):1378-85.
Score: 0.008
-
Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial. J Cosmet Dermatol. 2013 Dec; 12(4):261-6.
Score: 0.008
-
Safety of a novel microneedle device applied to facial skin: a subject- and rater-blinded, sham-controlled, randomized trial. Arch Dermatol. 2012 Jun; 148(6):711-7.
Score: 0.008